GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » PS Ratio

Nobel Biocare Holding AG (Nobel Biocare Holding AG) PS Ratio : 2.90 (As of May. 23, 2024)


View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Nobel Biocare Holding AG's share price is $18.25. Nobel Biocare Holding AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2013 was $6.29. Hence, Nobel Biocare Holding AG's PS Ratio for today is 2.90.

The historical rank and industry rank for Nobel Biocare Holding AG's PS Ratio or its related term are showing as below:

NBHGF's PS Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 3.29
* Ranked among companies with meaningful PS Ratio only.

Nobel Biocare Holding AG's Revenue per Sharefor the six months ended in Dec. 2013 was $6.29. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2013 was $6.29.

Back to Basics: PS Ratio


Nobel Biocare Holding AG PS Ratio Historical Data

The historical data trend for Nobel Biocare Holding AG's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG PS Ratio Chart

Nobel Biocare Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.96 2.78 1.91 1.37 2.47

Nobel Biocare Holding AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.96 2.78 1.91 1.37 2.47

Competitive Comparison of Nobel Biocare Holding AG's PS Ratio

For the Medical Instruments & Supplies subindustry, Nobel Biocare Holding AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nobel Biocare Holding AG's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nobel Biocare Holding AG's PS Ratio distribution charts can be found below:

* The bar in red indicates where Nobel Biocare Holding AG's PS Ratio falls into.



Nobel Biocare Holding AG PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Nobel Biocare Holding AG's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=18.25/6.29
=2.90

Nobel Biocare Holding AG's Share Price of today is $18.25.
For company reported annually, GuruFocus uses latest annual data as the TTM data. Nobel Biocare Holding AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2013 was $6.29.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Nobel Biocare Holding AG  (OTCPK:NBHGF) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Nobel Biocare Holding AG PS Ratio Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Traded in Other Exchanges
N/A
Address
Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines